Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Syddansk Universitet Forside
Hjælp og FAQ
Dansk
English
Forside
Forskere
Forskningsenheder
Publikationer
Aktiviteter
Projekter
Datasæt
Presse/medie
Priser
Undervisning
Impacts
Søg efter ekspertise, navn eller tilknytning
Vis Scopus-profil
Peter Aaby
Klinisk Institut
Professor
,
KI, OUH, Forskningsenhed for Open - Bandim
https://orcid.org/0000-0001-8331-1389
E-mail
paaby
health.sdu
dk
Oversigt
Fingeraftryk
Netværk
Publikationer
(326)
Aktiviteter
(10)
Projekter
(2)
Presse/medie
(34)
Lignende forskere
(9)
Ph.d.-vejledning
(3)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Peter Aaby er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Pharmacology, Toxicology and Pharmaceutical Science
Measles Vaccine
100%
Measles
82%
Oral Poliomyelitis Vaccine
62%
Infection
56%
Randomized Controlled Trial
52%
Mycobacterium Bovis BCG
48%
Mortality Rate
46%
Childhood Mortality
46%
Retinol
45%
Pertussis
39%
Tetanus
39%
Diphtheria
39%
Observational Study
33%
Diseases
33%
Prevalence
27%
Diphtheria Pertussis Tetanus Vaccine
26%
All Cause Mortality
24%
Cohort Study
23%
BCG Vaccine
19%
Live Vaccine
17%
Randomized Clinical Trial
17%
Infant Mortality
16%
Scar Formation
15%
Placebo
13%
Tuberculin
12%
Diarrhea
11%
Chloroquine
11%
Low Birth Weight
10%
Human Respiratory Syncytial Virus
9%
Cluster Randomized Trial
9%
Smallpox Vaccine
9%
Case Fatality Rate
8%
Pandemic
8%
Cytokine
8%
Measles Antibody
7%
Atopy
7%
Smallpox
7%
Rubella
7%
Mumps
7%
Infectious Agent
6%
Plasmodium falciparum
6%
Asthma
5%
Adverse Event
5%
Respiratory Tract Infection
5%
Haemophilus Influenzae Type B
5%
Diphtheria Pertussis Poliomyelitis Tetanus Vaccine
5%
Overall Survival
5%
Parasitemia
5%
Child Death
5%
Inactivated Vaccine
5%
Medicine and Dentistry
Oral Poliomyelitis Vaccine
48%
Retinol
48%
Supplementation
47%
Measles Vaccine
45%
Infection
41%
Childhood Mortality
41%
Mycobacterium Bovis BCG
36%
Mortality Rate
31%
Diseases
30%
Pertussis
29%
Diphtheria
29%
Tetanus
29%
Measles Vaccination
28%
Low Birth Weight
26%
Measles
25%
Randomized Controlled Trial
25%
BCG Vaccination
24%
Human Immunodeficiency Virus
23%
Cohort Analysis
21%
Diphtheria Pertussis Tetanus Vaccine
19%
BCG Vaccine
18%
Infant Mortality
18%
Randomized Clinical Trial
18%
Diarrhea
17%
Neonatal Infant
17%
Cluster Randomized Trial
16%
Hazard Ratio
15%
Surveillance System
13%
Vaccination Coverage
13%
Proportional Hazards Model
13%
Placebo
12%
Live Vaccine
12%
Prevalence
12%
All Cause Mortality
11%
Observational Study
11%
In Vitro
11%
Arm
10%
Salmonella
10%
Meta-Analysis
10%
Household
9%
Neonate
9%
Birth Weight
9%
Typhoid Fever
9%
Newborn Mortality
8%
Cytokine Response
8%
Smallpox Vaccine
8%
Nutritional Status
8%
Respiratory Tract Infection
8%
Pediatrics
7%
Atopy
7%
Immunology and Microbiology
Measles Vaccine
50%
Measles
37%
Prevalence
30%
Mycobacterium Bovis BCG
27%
Childhood Mortality
23%
Mortality Rate
18%
Measles Antibody
17%
Cytokine Response
16%
Oral Poliomyelitis Vaccine
15%
Infectious Agent
15%
Cytokine Production
15%
Immune Response
15%
BCG Vaccine
12%
Scar Formation
11%
Smallpox Vaccine
10%
Cytokine
9%
Tumor Necrosis Factor
9%
Drug Megadose
9%
Human Immunodeficiency Virus 1
9%
Tuberculin
9%
Low Birth Weight
9%
Innate Immune System
9%
Cryptosporidium
8%
Titer
8%
Newborn Mortality
7%
Salmonella
7%
Human Respiratory Syncytial Virus
7%
DPT Vaccine
7%
All Cause Mortality
6%
Leukocyte
6%
Maternal Antibody
6%
Infancy
5%
Immune System
5%
Interleukin 10
5%
Parasitemia
5%
Live Vaccine
5%
Attenuated Vaccine
5%
Booster Dose
5%
Atopy
5%
Human Immunodeficiency Virus
5%
